A Vicious Cycle: In Severe and Critically Ill COVID-19 PatientsReview Published on 2022-06-152023-07-09 Journal: Frontiers in Immunology [Category] COVID19(2023년), [키워드] COVID-19 endothelial cells IL-6 inflammatory reaction PAI-1 Tocilizumab Venous thrombosis [DOI] 10.3389/fimmu.2022.930673 PMC 바로가기 [Article Type] Review
Cerebral venous thrombosis during the COVID-19 Pandemic: A multi-center experienceResearch article Published on 2022-06-012022-10-05 Journal: Clinical neurology and neurosurgery [Category] 변종, [키워드] age anticoagulation association cerebral cerebral vein thrombosis Characteristics Clinical characteristics Comorbidity Complication coronavirus COVID COVID-19 COVID-19 infection Diagnosis hemorrhage Hospitalization hypertension Infection majority male Mortality objective outcome Patient positive COVID-19 Pulmonary emboli Radiographic Result stroke the patient treated vaccination Vaccine venous Venous thrombosis with COVID-19 [DOI] 10.1016/j.clineuro.2022.107256 [Article Type] Research article
No increased incidence of venous thrombosis or pulmonary embolism after SARS-CoV-2 vaccination in GermanyArticle Published on 2022-06-012023-07-08 Journal: Public health [Category] COVID19(2023년), [키워드] COVID-19 pandemic vaccination Venous thrombosis [DOI] 10.1016/j.puhe.2022.03.004 PMC 바로가기
Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reportsCase Reports Published on 2022-05-072023-07-09 Journal: Journal of Medical Case Reports [Category] COVID19(2023년), [키워드] ChAdOx1 nCoV-19 COVID 19 Covishield vaccine Superficial saphenous vein (SSV) Superficial venous thrombosis (SVT) Venous thrombosis [DOI] 10.1186/s13256-022-03407-6 PMC 바로가기 [Article Type] Case Reports
Clinical features of thrombosis and bleeding in COVID-19Research article Published on 2022-04-222022-10-05 Journal: Blood [Category] COVID19(2023년), SARS, 임상, [키워드] Admission appear Arterial thrombosis bleeding clinical COVID-19 COVID-19 disease COVID-19 symptom D-dimer dose events extracorporeal membrane oxygenation Factor feature fibrinogen higher risk hospital include indications Infection intensive care unit less Lymphocyte count Mortality multifactorial Myocardial infarction Other parameter Patient presenting pulmonary receive resulting risk Severe COVID-19 Infection stroke the patient the SARS-CoV-2 virus Thromboprophylaxis thrombosis treated Treatment unique venous Venous thrombosis von Willebrand factor VTE with COVID-19 [DOI] 10.1182/blood.2021012247 [Article Type] Research article
[Anticoagulation in coronavirus disease 2019 (COVID-19): confirmed and controversial aspects]Review Published on 2022-04-012023-07-08 Journal: Internist (Berl) [Category] COVID19(2023년), [키워드] COVID-19/prognosis fondaparinux heparin Microthrombosis Venous thrombosis [DOI] 10.1007/s00108-022-01296-x PMC 바로가기 [Article Type] Review
Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in SingaporeObservational Study Published on 2022-03-012022-10-04 Journal: JAMA Network Open [Category] SARS, 임상, [키워드] 95% CI age BNT162b2 caused cerebral Characteristics clinical Clinical characteristics conducted diagnosed dose hospital Hospitalization immunisation incidence incidence rate individual Infection male median Messenger RNA Moderna mRNA mRNA-1273 mRNA-based mRNA-based SARS-CoV-2 vaccines Observational cohort study occur outcome patients hospitalized Perspective Pfizer-BioNTech positive serology Quantitative registry remained report SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination SARS-CoV-2 vaccine significantly higher Singapore the median vaccination Vaccine Venous thrombosis [DOI] 10.1001/jamanetworkopen.2022.2940 PMC 바로가기 [Article Type] Observational Study
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in EnglandResearch Article Published on 2022-02-222022-10-29 Journal: PLoS Medicine [Category] COVID-19, COVID19(2023년), SARS, [키워드] absolute increase Accuracy adjusted Adults age age and sex analysed Analysis anticoagulant medication antiplatelet Asian association black blood pressure BNT162b2 BNT162b2 vaccines case finding ChAdOx1 ChAdOx1-S coded cohort study confidence interval confounding factors Coronavirus infection covariate covariates COVID-19 COVID-19 mortality COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines Deprivation diabetes diagnostic dose DVT Effect effort Electronic health record Electronic health records England estimate estimates event first vaccination Frequency hazard ratio healthcare Hospital admission hospitalisation hospitalised HRs hypertension identify IMPROVE incidence incidence rate increase in increased risk increases in limitation medication morbidity morbidity and mortality Myocardial infarction outcome performed Platelet population level population-based cohort Positive predictive value prevaccination Rate reducing reported researcher residual confounding risk selected Sex smoking stroke therapy threshold thrombosis thrombotic event Thrombotic events vaccination Vaccine Vaccines venous Venous thrombosis white William [DOI] 10.1371/journal.pmed.1003926 PMC 바로가기 [Article Type] Research Article
Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccinesResearch article Published on 2022-02-012022-10-05 Journal: Medical Hypotheses [Category] 변종, [키워드] Adenoviridae Adenovirus affected antibody binding caused Coagulation complex COVID-19 vaccines described DNA Factor X healthcare immune response Immunity Impaired impairment individuals mechanism Mutation offer option Platelet platelet activation PROTECT Protein stimulate thrombocytopenia thromboembolic complication Thromboembolic event thrombotic event Vaccine Vaccines Venous thrombosis virus [DOI] 10.1016/j.mehy.2021.110756 [Article Type] Research article
COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohortResearch Article Published on 2022-01-122022-10-28 Journal: PLoS ONE [Category] COVID-19, [키워드] 95% CI adjusted Analysis antithrombotic therapy calculated Coagulation Cohort COVID-19 COVID-19 patient Cox proportional hazard dataset demonstrated diagnosed diagnosed with COVID-19 diagnosis of COVID-19 DVT EHR evaluated hazard ratio Health higher risk HRs identify independent Influenza insight knowledge median age medication Myocardial infarction outcome Patient patients with COVID-19 Propensity score Result retrospective retrospective cohort risk SARS-CoV-2 SARS-COV-2 infection secondary secondary outcome stroke Thromboembolic event thromboembolic risk thrombosis variables venous thromboembolic Venous thrombosis were assessed women [DOI] 10.1371/journal.pone.0261786 PMC 바로가기 [Article Type] Research Article